跳至主要内容
临床试验/NCT02298972
NCT02298972已完成不适用

Symptom Support During Chemotherapy: A Mixed Method Study in Adult Patients With Cancer

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家目标入组 143 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
143
试验地点
1
主要终点
Overall symptom distress

研究概览

简要总结

This study evaluates the value of a nursing symptom support en selfmanagement intervention for adult patients with cancer treated with chemotherapy. Using a prospective sequential design with a comparison group who receives standard care and a (later) intervention group who gets the nursing intervention, we will evaluate the effect of this nursing intervention on overall symptom distress (primary outcome) and other measures of symptom burden, self-efficacy, outcome expectations and self-care. By conducting sem-structured interviews with some participants of the intervention group, we will study the patient experience of the intervention.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients starting first line treatment with (intravenous) chemotherapy
  • Ambulatory patients or patients who receive their treatment during short hospital stays
  • Regardless of type of cancer, treatment or treatment intention (curative or palliative)
  • Who understand sufficiently Dutch to fill out questionnaires
  • Who sign informed consent for their participation in the study

排除标准

  • Oral anticancer treatment
  • Concomitant chemoradiotherapy
  • Breast cancer patients who receive nurse counseling throughout their therapy
  • Experimental therapy in the context of a clinical trial

结局指标

主要结局

Overall symptom distress

时间窗: Longitudinal, during first 3 months after start of treatment

Summed symptom distress as self-reported on the Symptom Burden Questionnaire

Overall symptom severity

时间窗: Longitudinal, during first 3 months after start of treatment

Summed symptom severity as self-reported on the Symptom Burden Questionnaire

次要结局

  • Total self-efficacy score(Day 43 of treatment (+/- 1 week))
  • Total outcome expectations score(Day 43 of treatment (+/- 1 week))
  • Total self-care score(Day 85 of treatment (+/- 1 week))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Annemarie Coolbrandt

Clinical Nurse Specialist oncology

Universitaire Ziekenhuizen KU Leuven

研究点 (1)

Loading locations...

相似试验